Keith A. Goldan, CFO: Syndax Pharmaceuticals SNDX Sell · Filed 02/10

Trade details

Type: Insider sale
Amount: $71,712.3
Shares · price: 3,410 sh · $21.03 a share
Held after: 140,429 sh
Stock: Syndax Pharmaceuticals SNDX
Person: Keith A. GoldanCFO
Trade date: 26/02/09
Filed: 26/02/10
Days to filing: 1 days

Sold 2.4% of holdings

Share of holding sold: 2.4%

Syndax Pharmaceuticals trades, last 26 weeks

What else happened in Syndax Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/10~03/11

Keith A. Goldan's recent trades

Keith A. GoldanCFO
SellSyndax Pharmaceuticals
Sell
Syndax Pharmaceuticals
SNDX
$22.4K
1,177 sh
$22.4K
Filed 06/02
Traded 06/01
Keith A. GoldanCFO
Planned saleSyndax Pharmaceuticals
Planned sale
Syndax Pharmaceuticals
SNDX
$22.4K
1,177 sh
$22.4K
Filed 06/01
Traded 06/01
Keith A. GoldanCFO
Planned saleSyndax Pharmaceuticals
Planned sale
Syndax Pharmaceuticals
SNDX
$71.7K
3,410 sh
$71.7K
Filed 02/09
Traded 02/09
Keith A. GoldanCFO
SellSyndax Pharmaceuticals
Sell
Syndax Pharmaceuticals
SNDX
$42.9K
2,082 sh
$42.9K
Filed 02/06
Traded 02/06
Keith A. GoldanCFO
Planned saleSyndax Pharmaceuticals
Planned sale
Syndax Pharmaceuticals
SNDX
$42.9K
2,082 sh
$42.9K
Filed 02/06
Traded 02/06